Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits 29.73% Profit Target as Forecasted by QuantWave

May 30, 2025
REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) achieved a significant milestone as it hit the price target forecasted by QuantWave, providing investors with a profit of 29.73%. The forecast signal was issued on February 28, 2025, with a price of $697.71 and a predicted direction of short. On May 30, 2025, the stock reached the target price of $490.28, confirming the accuracy of QuantWave's analytics.

This success highlights the effectiveness of QuantWave's automated forecasting platform in predicting stock movements. The achievement of the price target for REGENERON PHARMACEUTICALS, INC. demonstrates the valuable insights provided by QuantWave to investors, enabling them to make informed decisions and generate profits in the market.

In the broader context of QuantWave's analytics, this forecast success reaffirms the platform's capabilities in offering accurate predictions for a wide range of stocks. Investors can leverage QuantWave to access forecasting signals and opportunities for potential profits in the stock market.

For those interested in exploring the investment strategy behind QuantWave further, QuantSchool offers educational resources on the professional investment framework utilized by the platform. QuantSchool provides insights into the key principles for generating consistent income using the QuantWave forecasting system, empowering investors to make informed investment decisions.

Find out how the REGENERON PHARMACEUTICALS, INC. rate is expected to change

Get Forecast for REGN
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for REGN

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits Short Forecast Target with 17.43% Profit  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on July 1, 2022, predicted a short direction with a price of $593.76....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 21.51% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profitable outcome for investors....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with a Profit of 30.6%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 30.6% for investors who followed the short signal....



Related news

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted the short movement for REGENERON PHARMACEUTICALS, INC. with a price target of 572.6 $ on 2025-04-04, achieving a profit of 16.52%....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....

REGNApril 10, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.79% Profit: QuantWave's Success  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 17.79%....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....